Annual Total Expenses
$216.33 M
+$85.77 M+65.69%
December 31, 2023
Summary
- As of February 8, 2025, BCYC annual total expenses is $216.33 million, with the most recent change of +$85.77 million (+65.69%) on December 31, 2023.
- During the last 3 years, BCYC annual total expenses has risen by +$153.98 million (+246.96%).
- BCYC annual total expenses is now at all-time high.
Performance
BCYC Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$66.20 M
+$10.09 M+17.99%
September 30, 2024
Summary
- As of February 8, 2025, BCYC quarterly total expenses is $66.20 million, with the most recent change of +$10.09 million (+17.99%) on September 30, 2024.
- Over the past year, BCYC quarterly total expenses has increased by +$10.09 million (+17.99%).
- BCYC quarterly total expenses is now at all-time high.
Performance
BCYC Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BCYC Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +65.7% | +18.0% |
3 y3 years | +247.0% | +18.0% |
5 y5 years | +649.0% | +18.0% |
BCYC Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +179.8% | at high | +205.4% |
5 y | 5-year | at high | +439.5% | at high | +559.1% |
alltime | all time | at high | +1083.9% | at high | +1062.1% |
Bicycle Therapeutics Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $66.20 M(+18.0%) |
Jun 2024 | - | $56.11 M(+9.3%) |
Mar 2024 | - | $51.32 M(-14.1%) |
Dec 2023 | $216.33 M(+65.7%) | $59.75 M(+7.8%) |
Sep 2023 | - | $55.44 M(+1.0%) |
Jun 2023 | - | $54.90 M(+18.7%) |
Mar 2023 | - | $46.25 M(+30.5%) |
Dec 2022 | $130.56 M(+68.9%) | $35.43 M(+7.4%) |
Sep 2022 | - | $33.00 M(+6.5%) |
Jun 2022 | - | $31.00 M(-0.4%) |
Mar 2022 | - | $31.13 M(+43.6%) |
Dec 2021 | $77.31 M | $21.68 M(+15.4%) |
Sep 2021 | - | $18.78 M(-1.5%) |
Jun 2021 | - | $19.07 M(+7.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $17.79 M(-12.0%) |
Dec 2020 | $62.35 M(+55.5%) | $20.21 M(+46.8%) |
Sep 2020 | - | $13.77 M(-3.4%) |
Jun 2020 | - | $14.25 M(+11.6%) |
Mar 2020 | - | $12.77 M(+27.1%) |
Dec 2019 | $40.10 M(+38.8%) | $10.04 M(-7.6%) |
Sep 2019 | - | $10.87 M(+14.3%) |
Jun 2019 | - | $9.51 M(-1.7%) |
Mar 2019 | - | $9.68 M(+12.5%) |
Dec 2018 | $28.88 M(+58.1%) | $8.60 M(+7.9%) |
Sep 2018 | - | $7.97 M(+20.4%) |
Jun 2018 | - | $6.62 M(+16.2%) |
Mar 2018 | - | $5.70 M |
Dec 2017 | $18.27 M | - |
FAQ
- What is Bicycle Therapeutics annual total expenses?
- What is the all time high annual total expenses for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual total expenses year-on-year change?
- What is Bicycle Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly total expenses year-on-year change?
What is Bicycle Therapeutics annual total expenses?
The current annual total expenses of BCYC is $216.33 M
What is the all time high annual total expenses for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual total expenses is $216.33 M
What is Bicycle Therapeutics annual total expenses year-on-year change?
Over the past year, BCYC annual total expenses has changed by +$85.77 M (+65.69%)
What is Bicycle Therapeutics quarterly total expenses?
The current quarterly total expenses of BCYC is $66.20 M
What is the all time high quarterly total expenses for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly total expenses is $66.20 M
What is Bicycle Therapeutics quarterly total expenses year-on-year change?
Over the past year, BCYC quarterly total expenses has changed by +$10.09 M (+17.99%)